Medical device company ResMed (NYSE:RMD) in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit ...

Toolmaking and engineering pattern-making was once a thriving industry and is still a critical part of the supply chain in ...

Fresenius Medical Care gets a hold rating, as I share the neutral sentiment of Wall St today in my first coverage of this ...